Suchergebnisse - "Dodds, Michael G."

PubPharm (2)

1

Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

enthalten in: Journal of clinical pharmacology | 2017

von Gibbs, J. | Doshi, S. | Kuchimanchi, M. | +7

2

A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design

enthalten in: mAbs | 2014

von Davda, J. | Dodds, M. | Gibbs, M. | +2

1
[1]